# The COVID-19 Back-to-Normal Study: Analysis of Multiple Outcomes

> **NCT04832932** · — · UNKNOWN · sponsor: **Mebo Research, Inc.** · enrollment: 2000 (actual)

## Conditions studied

- COVID-19 Vaccines

## Interventions

- **BIOLOGICAL:** COVID-19 vaccines

## Key facts

- **NCT ID:** NCT04832932
- **Lead sponsor:** Mebo Research, Inc.
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-05
- **Primary completion:** 2023-01-05
- **Final completion:** 2025-01-05
- **Target enrollment:** 2000 (ACTUAL)
- **Last updated:** 2024-01-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04832932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04832932, "The COVID-19 Back-to-Normal Study: Analysis of Multiple Outcomes". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT04832932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*